X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs STERLING BIOTECH - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN STERLING BIOTECH LUPIN/
STERLING BIOTECH
 
P/E (TTM) x 38.1 -0.4 - View Chart
P/BV x 2.3 0.0 16,404.1% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 LUPIN   STERLING BIOTECH
EQUITY SHARE DATA
    LUPIN
Mar-18
STERLING BIOTECH
Dec-13
LUPIN/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,46511 13,952.4%   
Low Rs7273 21,385.3%   
Sales per share (Unadj.) Rs349.626.8 1,304.1%  
Earnings per share (Unadj.) Rs5.6-15.0 -37.2%  
Cash flow per share (Unadj.) Rs29.6-5.5 -541.4%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs300.354.9 547.2%  
Shares outstanding (eoy) m452.08267.87 168.8%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.10.3 1,209.3%   
Avg P/E ratio x197.2-0.5 -42,440.3%  
P/CF ratio (eoy) x37.1-1.3 -2,912.7%  
Price / Book Value ratio x3.60.1 2,881.9%  
Dividend payout %90.00-   
Avg Mkt Cap Rs m495,5021,862 26,615.6%   
No. of employees `00017.01.4 1,258.6%   
Total wages/salary Rs m28,647547 5,239.0%   
Avg. sales/employee Rs Th9,273.65,303.3 174.9%   
Avg. wages/employee Rs Th1,681.0403.8 416.2%   
Avg. net profit/employee Rs Th147.4-2,959.0 -5.0%   
INCOME DATA
Net Sales Rs m158,0427,181 2,200.9%  
Other income Rs m1,50443 3,529.3%   
Total revenues Rs m159,5457,223 2,208.8%   
Gross profit Rs m31,475947 3,324.0%  
Depreciation Rs m10,8592,543 427.0%   
Interest Rs m2,0444,377 46.7%   
Profit before tax Rs m20,076-5,931 -338.5%   
Minority Interest Rs m-710-   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,885-1,924 -149.9%   
Profit after tax Rs m2,513-4,007 -62.7%  
Gross profit margin %19.913.2 151.0%  
Effective tax rate %14.432.4 44.3%   
Net profit margin %1.6-55.8 -2.8%  
BALANCE SHEET DATA
Current assets Rs m122,09514,335 851.7%   
Current liabilities Rs m50,95649,809 102.3%   
Net working cap to sales %45.0-494.0 -9.1%  
Current ratio x2.40.3 832.6%  
Inventory Days Days85403 21.0%  
Debtors Days Days120171 70.3%  
Net fixed assets Rs m129,87655,432 234.3%   
Share capital Rs m904268 337.5%   
"Free" reserves Rs m134,86613,935 967.8%   
Net worth Rs m135,77114,701 923.5%   
Long term debt Rs m64,2459,478 677.8%   
Total assets Rs m263,05473,988 355.5%  
Interest coverage x10.8-0.4 -3,049.5%   
Debt to equity ratio x0.50.6 73.4%  
Sales to assets ratio x0.60.1 619.0%   
Return on assets %1.70.5 345.8%  
Return on equity %1.9-27.3 -6.8%  
Return on capital %3.7-6.4 -57.9%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m53,1411,860 2,857.4%   
Fx outflow Rs m19,33525 77,680.6%   
Net fx Rs m33,8071,835 1,842.4%   
CASH FLOW
From Operations Rs m17,5121,719 1,018.9%  
From Investments Rs m-14,073-3,148 447.0%  
From Financial Activity Rs m-14,9211,426 -1,046.3%  
Net Cashflow Rs m-11,482-3 337,697.1%  

Share Holding

Indian Promoters % 46.6 33.9 137.5%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 31.9 9.9 322.2%  
ADR/GDR % 0.0 16.9 -  
Free float % 10.1 39.3 25.7%  
Shareholders   98,259 21,482 457.4%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   GSK PHARMA  NATCO PHARMA  BIOCON   PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 66 Points Higher; Realty and Consumer Durable Stocks Witness Buying(Closing)

Indian share markets continued to witness volatility during closing hours and ended their day on a flat note.

Related Views on News

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Jun 19, 2019 (Close)

TRACK LUPIN

LUPIN - JUBILANT LIFE SCIENCES COMPARISON

COMPARE LUPIN WITH

MARKET STATS